Senators question basis for FDA’s digital health pre-cert pilot

This article was originally published here

Sens. Elizabeth Warren (D-Mass., left), Tina Smith (D-Minn., center) and Patty Murray (D-Wash. right) [Images are public domain]

Three Democratic senators representing major high tech and medtech hubs in the United States are questioning the statutory basis of FDA’s new pilot program for digital health product precertification.

“We support FDA’s efforts to update the medical device review regime to better accommodate digital health devices and believe that it is an important step in ensuring that America remains an innovative, cutting-edge producer of medical devices. However, it is essential that changes to FDA’s regulatory framework are done in compliance with the current statutory framework and do not compromise public safety.” Sens. Elizabeth Warren (D-Mass.), Tina Smith (D-Minn.) and Patty Murray (D-Wash.) wrote in a letter dated Oct. 10 to FDA Commissioner Scott Gottlieb.

Their letter requests a response from Gottlieb by Nov. 9. FDA plans to respond directly to the senators, said agency spokesperson Stephanie Caccomo.

Get the full story on our sister site Medical Design & Outsourcing. 

The post Senators question basis for FDA’s digital health pre-cert pilot appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply